OPRXOptimizeRx Corp.Healthcare · Medical - Healthcare Information Servicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $7.53 · now $7.53 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, OPRX has typically landed between $5.16 and $10.04 — a range of −31.4% to +33.4% from the issuance price $7.53.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,695 overlapping 1 month windows · 2007-11-282026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.53) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where OPRX has typically landed a month from the 2026-09-16 close of $7.53 — the range is history, not a prediction.

$5.16worst · -31.4%$10.04best · +33.4%
  • now $7.53 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $7.31 (-2.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $6.31$8.32
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $5.16$10.04
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,695 windows spanning 2007-11-28 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2009-08-13−86.2%−86.2%+0.0%
2009-08-21−86.0%−86.0%+0.0%
2009-08-17−84.8%−84.8%+0.0%
3 best
2009-09-24+530.0%+0.0%+775.0%
2009-09-30+275.0%+0.0%+337.5%
2008-03-18+265.9%−2.4%+265.9%

4,695 overlapping windows · 2007-11-282026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
53%
+5.1%
n=19
Feb
37%
−0.1%
n=19
Mar
32%
−1.5%
n=19
Apr
53%
−0.1%
n=19
May
53%
+10.0%
n=19
Jun
68%
+1.7%
n=19
Jul
47%
+3.6%
n=19
Aug
42%
+3.2%
n=19
Sep
37%
−2.7%
n=19
Oct
39%
+10.3%
n=18
Nov
50%
+5.6%
n=18
Dec
32%
−5.2%
n=19

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$22$52025-12-19: 1 insider sale, $19K — Stelmakh Edward2025-10-03: 1 insider sale, $30K — Silvestro Stephen L2025-08-28: 1 insider sale, $194K — Spangler Patrick D2025-08: 1 open-market sale, $194K2025-10: 1 open-market sale, $30K2025-12: 1 open-market sale, $19K↑ buys↓ salesofficer Stelmakh Edward — Sale on 2025-12-19, filed 3 days after the tradeofficer Silvestro Stephen L — Sale on 2025-10-03, filed 4 days after the tradedirector Spangler Patrick D — Sale on 2025-08-28, filed 14 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2025-12-19Stelmakh EdwardofficerSale1,388 @ $13.51$19K−1.1% of holding−12.7%−73.2%126,830Form 4 · filed 3 days after the trade
2025-10-03Silvestro Stephen LofficerSale1,620 @ $18.75$30K−0.9% of holding+1.6%−63.6%188,916Form 4 · filed 4 days after the trade
2025-08-28Spangler Patrick DdirectorSale11,120 @ $17.49$194K−20.1% of holding+9.9%−65.8%44,215Form 4 · filed 14 days after the trade
2025-03-14Lang James PauldirectorPurchase321,408 @ $7.60$2.4M+472.4% of holding+11.1%+104.9%389,452Form 4 · filed 5 days after the trade
2024-12-12FEBBO WILLIAM JdirectorPurchase20,000 @ $5.01$100K+3.4% of holding+1.8%+172.3%601,253Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

122 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-01D'Silva Andrew J.officerWithheld for tax1,43299,660Form 4
2026-08-21Silvestro Stephen LofficerWithheld for tax1,737183,551Form 4
2026-08-21Odence-Ford MarionofficerWithheld for tax1,52990,407Form 4
2026-08-21Stelmakh EdwardofficerWithheld for tax1,381121,791Form 4
2026-08-21D'Silva Andrew J.officerWithheld for tax1,24343,492Form 4
2026-08-21Merrell Brendan W.officerWithheld for tax1,02025,187Form 4
2026-08-20Silvestro Stephen LofficerAward / grant79,200262,751Form 4
2026-08-20Odence-Ford MarionofficerAward / grant57,600148,007Form 4
2026-08-20Merrell Brendan W.officerAward / grant57,60082,787Form 4
2026-08-20D'Silva Andrew J.officerAward / grant57,600101,092Form 4
2026-06-09WASSON GREGORY DdirectorAward / grant34,51791,700Form 4
2026-06-09Spangler Patrick DdirectorAward / grant34,51778,732Form 4
2026-06-09Presti Mariyamma VarghesedirectorAward / grant17,25830,318Form 4
2026-06-09Vos Ellen O'ConnordirectorAward / grant34,517107,159Form 4
2026-06-09KLEMA CATHYdirectorAward / grant34,51756,137Form 4
2026-06-09Lang James PauldirectorAward / grant34,517433,837Form 4
2026-05-15Silvestro Stephen LofficerWithheld for tax5,219185,288Form 4
2026-05-15Greco TheresaofficerWithheld for tax91471,954Form 4
2026-05-15Greco TheresaofficerWithheld for tax87971,075Form 4
2026-05-01Presti Mariyamma VarghesedirectorAward / grant13,06013,060Form 4
2026-02-11Odence-Ford MarionofficerWithheld for tax1,38691,936Form 4
2026-02-11Odence-Ford MarionofficerOption exercise4,0000Form 4
2026-02-11Odence-Ford MarionofficerOption exercise4,00093,322Form 4
2026-02-11Odence-Ford MarionofficerOption exercise4,00093,322Form 4
2025-12-23Besch DougofficerWithheld for tax4,07966,876Form 4
2025-12-23Odence-Ford MarionofficerWithheld for tax4,05189,322Form 4
2025-12-23Stelmakh EdwardofficerWithheld for tax3,658123,172Form 4
2025-12-23Silvestro Stephen LofficerWithheld for tax3,361190,507Form 4
2025-12-23Greco TheresaofficerWithheld for tax1,42072,868Form 4
2025-12-19Silvestro Stephen LofficerWithheld for tax1,594193,868Form 4
2025-12-19Odence-Ford MarionofficerWithheld for tax1,15393,373Form 4
2025-12-19D'Silva Andrew J.officerWithheld for tax70344,735Form 4
2025-12-19Besch DougofficerWithheld for tax58170,955Form 4
2025-12-19Merrell Brendan W.officerWithheld for tax28926,207Form 4
2025-12-19Odence-Ford MarionofficerOption exercise3,92894,526Form 4
2025-12-19Besch DougofficerOption exercise1,96471,536Form 4
2025-12-19Besch DougofficerOption exercise1,9641,964Form 4
2025-12-19Odence-Ford MarionofficerOption exercise3,9283,928Form 4
2025-12-19Silvestro Stephen LofficerOption exercise6,546195,462Form 4
2025-12-19Silvestro Stephen LofficerOption exercise6,5466,547Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.